Shionogi Chief Eyes Conditional Approval for COVID-19 Vaccine, Supply by Year’s End If OK’ed

Shionogi is exploring the possibility of conditional approval for its COVID-19 vaccine, which is now in PI/II development in Japan, to accelerate its delivery to Japanese people, President Isao Teshirogi said on a conference call on May 10. “How to...read more